Stay updated with breaking news from Accelerate Cures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Children's Hospital of Philadelphia has helped launch a new computational platform that will harmonize pediatric cancer data, allowing researchers, pharmaceutical companies, and advocacy groups to accelerate the pace of drug development for pediatric cancer.
--The NCI-backed 'Molecular Targets Platform' will streamline and catalyze drug development by harmonizing data about pediatric cancer targets and...
06/09/22 Pharmaceutical Online Newsletter
The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...
The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...